[144] SOPHiA GENETICS SA SEC Filing

Rhea-AI Filing Summary

SOPH filed a Form 144 notice for a proposed sale of 3,866 common shares. The shares were acquired as restricted stock units on 10/02/2025 and are slated for sale on or about 10/03/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ. The filing lists an aggregate market value of $17,281.02 for the proposed shares and notes 67,579,560 shares outstanding.

The notice also details recent Rule 10b5-1 sales over the past three months: 09/19/2025 (381 shares; $1,211.35), 08/19/2025 (380; $1,304.01), 07/23/2025 (66; $226.38), 07/21/2025 (381; $1,349.54), and 07/07/2025 (1,703; $5,155.49).

Insights

Securities law analyst

Administrative Form 144 for a modest planned insider sale.

The filing lists a proposed sale of 3,866 common shares via Morgan Stanley Smith Barney LLC with an $17,281.02 aggregate market value. The shares were acquired as restricted stock units on 10/02/2025, with the approximate sale date on 10/03/2025 and trading on NASDAQ.

The document also itemizes recent Rule 10b5-1 sales over the prior three months with specific amounts and gross proceeds. The issuer’s shares outstanding are disclosed as 67,579,560, which provides scale but does not change the mechanics of this notice.

Form 144 is a notice of proposed sales by affiliates or holders of restricted stock. Actual sales depend on market conditions and applicable Rule 144 limits; the filing itself does not indicate execution timing beyond the stated approximate date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3866	17281.02	67579560	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Restricted Stock Units	Issuer			3866	10/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	09/19/2025	381	1211.35
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	08/19/2025	380	1304.01
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	07/23/2025	66	226.38
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	07/21/2025	381	1349.54
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2025	1703	5155.49

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did SOPH disclose in this Form 144 filing?

A proposed sale of 3,866 common shares with an $17,281.02 aggregate market value, to be sold on or about 10/03/2025 on NASDAQ.

How were the SOPH shares to be sold acquired?

The filing states they were acquired as restricted stock units on 10/02/2025.

Which broker is listed for the SOPH Form 144 sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services, New York.

How many SOPH shares are outstanding according to the notice?

The filing lists 67,579,560 shares outstanding.

What recent SOPH 10b5-1 sales are reported in the filing?

Reported sales include 09/19/2025 (381; $1,211.35), 08/19/2025 (380; $1,304.01), 07/23/2025 (66; $226.38), 07/21/2025 (381; $1,349.54), and 07/07/2025 (1,703; $5,155.49).

On which exchange will the SOPH shares be sold?

The filing identifies NASDAQ as the exchange.

What is the approximate date of the SOPH share sale in the Form 144?

The notice lists 10/03/2025 as the approximate date of sale.